Visningssätt för begreppens/termernas förhållanden:
Det sätt begreppsrelationer visas:
Det sätt begreppsrelationer visas:
Kliniska prövningar, fas I
Hierarki: | ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I 5 sidobegrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I 5 sidobegrepp∟ ∟ ∟ ∟ ∟ |
Bredare villkor: | ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I ∟ ∟ ∟ ∟ Kliniska prövningar, fas I ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Kliniska prövningar, fas I |
Anmärkning: | |
Anmärkning: | Studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries.
X |
Annotation: | for U.S. & foreign studies; for I/II clin trials, index under CLINICAL TRIALS, PHASE I + CLINICAL TRIALS, PHASE II; IM for articles & books about phase I clin trials as a method in med research; do not confuse with Publication Type CLINICAL TRIAL, PHASE I; DF: CLIN TRIALS PHASE I
X |
historyNote*: | 93; DRUG EVALUATION, FDA PHASE I was see DRUG EVALUATION 1980-92; EVALUATION STUDIES, FDA PHASE I was EVALUATION STUDIES, DRUG, FDA PHASE I see DRUG EVALUATION 1982-92
X |
onlineNote*: | use DRUG EVALUATION to search DRUG EVALUATION, FDA PHASE I 1980-92 & EVALUATION STUDIES, DRUG, FDA PHASE I 1982-92
X |
publicMeSHNote*: | 93; DRUG EVALUATION, FDA PHASE I was see DRUG EVALUATION 1980-92; EVALUATION STUDIES, FDA PHASE I was EVALUATION STUDIES, DRUG, FDA PHASE I see DRUG EVALUATION 1982-92
X |
activeMeSHYear*: | 2007X |
dateCreated*: | 1992-05-13X |
dateEstablished*: | 1993-01-01X |
dateRevised*: | 2006-07-05X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | ssbX |
recordOriginator*: | TPWX |
Relaterad term: | |
Typ: | |
Samordna villkor: | |
URI: | |
Termer och motsvarande begrepp: | Kliiniset kokeet, vaihe I (fi) XKliininen koe, vaihe I (fi, ersatt) Vaiheen I kliininen kos (fi, ersatt) Vaiheen I kliiniset kokeet (fi, ersatt) Clinical Trials, Phase I (en) Phase I Clinical Trials (en, ersatt) Phase 1 Clinical Trials (en, ersatt) Drug Evaluation, FDA Phase 1 (en, ersatt) Evaluation Studies, FDA Phase 1 (en, ersatt) Human Microdosing Trials (en, ersatt) Clinical Trials, Phase 1 (en, ersatt) |
Dela: |
Laddar resultat...